BetterHealthGuy Blogcasts Episode #115: Joint Hypermobility and EDS with Michael McEvoy
Why You Should Listen:
In this episode, you will learn about Joint Hypermobility Syndrome and Ehlers-Danlos Syndrome.
About My Guest:
My guest for this episode is Michael McEvoy. Michael McEvoy is the founder of Metabolic Healing and co-founder of TrueReport, a NutriGenomics assessment. Michael is recognized as a thought leader, systems creator, educator, and integrator of diverse clinical modalities. Michael has created the Metabolic Healing Institute out of the need for deeper clinical applications and clarity of vision in the field of functional medicine and integrative healthcare. Through unique educational and teaching endeavors, Michael’s objective is to assemble a network of the world’s top clinicians to meet the demands and challenges of 21st century functional medicine and to implement the analytical tools and frameworks required.
Key Takeaways:
- What are the symptoms of joint hypermobility syndrome?
- What is the role of the extracellular matrix in joint hypermobility?
- What is the interplay between the ECM and the immune system?
- How is the ECM involved in Cell Danger Response?
- Could mast cell stabilizers potentially impede healing?
- What is Ehlers-Danlos Syndrome?
- What are the triggers for joint hypermobility and EDS?
- What is the Cusack Protocol for EDS?
- What tools have proven helpful in hypermobility and EDS?
- What is the role of RCCX in complex, chronic illness?
- Is there a connection between EDS and Craniocervical Instability?
Connect With My Guest:
Interview Date:
March 20, 2020
Transcript:
To review a transcript of this show, visit https://BetterHealthGuy.com/Episode115.
Additional Information:
To learn more, visit https://BetterHealthGuy.com.
Disclaimer:
The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority.